Latest Articles
New cotton variety delivers quality benefits - Goondiwindi Argus
New cotton variety delivers quality benefits Goondiwindi Argus
Published: June 23, 2026, 10 p.m.
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer - OncLive
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer OncLive
Published: June 20, 2026, 1:04 p.m.
Worker at former Marsden Point refinery flown to hospital after medical emergency - RNZ
Worker at former Marsden Point refinery flown to hospital after medical emergency RNZ
Published: June 18, 2026, 6:20 a.m.
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer - OncLive
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer OncLive
Published: June 17, 2026, 9:31 p.m.
Pre-trial Rulings Define What Jurors Will Hear In Aaron Spencer Case Happy Mothers Day Message (FIK1pN8bUy) - Fathom Journal
Pre-trial Rulings Define What Jurors Will Hear In Aaron Spencer Case Happy Mothers Day Message (FIK1pN8bUy) Fathom Journal
Published: June 16, 2026, 11:06 a.m.
The Hon Patrick Gorman MP Television interview – ABC Afternoon Briefing - The National Tribune
The Hon Patrick Gorman MP Television interview – ABC Afternoon Briefing The National Tribune
Published: June 9, 2026, 2:17 a.m.
Infertility may pull menopause forward, study finds - Benefits and Pensions Monitor
Infertility may pull menopause forward, study finds Benefits and Pensions Monitor
Published: June 8, 2026, 12:33 p.m.
“World Breastfeeding” Week – Providing Advice For Mothers & Benefits For Babies - Bệnh viện FV
“World Breastfeeding” Week – Providing Advice For Mothers & Benefits For Babies Bệnh viện FV
Published: June 5, 2026, 6:31 p.m.
PhilHealth expands maternity, gynecologic care benefits - ABS-CBN
PhilHealth expands maternity, gynecologic care benefits ABS-CBN
Published: June 4, 2026, 9:10 a.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post
Published: June 3, 2026, 2:49 p.m.
Link copied to clipboard!